Despite advances in the management of acute myocardial infarction (MI), up to 38% of patients will experience signs of heart failure and many will have a reduced left ventricular ejection fraction. Sodium-glucose cotransporter 2 inhibitors have well-documented cardiovascular benefits; however, data about their usefulness after an acute MI are limited.
New Endocrine Society guidelines provide updated recommendations for vitamin D testing and supplementation. Screening tests are not cost-effective but supplementation may be beneficial in several patient populations.
This resource page contains an annotated list of current guidelines and landmark clinical trials related to the management of patients with substance use disorders.
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.
Loading ...